Levi & Korsinsky Reminds Shareholders of an Investigation into Valneva SE (VALN) Regarding Potential Securities Fraud Allegations
Portfolio Pulse from
Levi & Korsinsky has initiated an investigation into Valneva SE (NASDAQ:VALN) for potential securities fraud. This follows a CDC notice about hospitalizations linked to Valneva's chikungunya vaccine.
March 04, 2025 | 10:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Valneva SE is under investigation for potential securities fraud following CDC's report of hospitalizations linked to its chikungunya vaccine.
The investigation by Levi & Korsinsky into Valneva SE for potential securities fraud is significant due to the CDC's report of adverse events linked to its vaccine. This could negatively impact investor confidence and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100